PATENT CLAIM ANALYSIS

Application Number: 15566955
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "255010"]

Abstract:
This invention relates to a derivative of the general formula (I), as follows: or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof for use as a medicament for the treatment and/or prevention of muscle atrophy in mammals and/or for limiting muscular atrophy in mammals and/or to promote muscle growth in exercising mammals aimed at increasing muscle mass and quality, preventing the occurrence of symptoms of sarcopenia related to age or rehabilitation after a muscle loss, age-related muscle atrophy and/or the consequences of drug therapy and/or immobilization and/or cachexia.

Claim (Index 4):
Derivative for use according to  claim 1 , characterized in that n=1;

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.56716
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15311967', '12919007', '13194434', '12281309', '14335853']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7795686023502316
- 35 USC 102 Novelty (BERT): 0.5257916329471894
- Combined Prediction Score: 0.7541909054099274
- Mean Citation Score: 211.535924
- Max Citation Score: 261.41336
- Similarity Product: 128.75243111083748

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test